X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA TORRENT PHARMA NATCO PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 30.7 29.0 105.6% View Chart
P/BV x 23.2 5.5 420.6% View Chart
Dividend Yield % 0.5 1.0 49.9%  

Financials

 NATCO PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
TORRENT PHARMA
Mar-17
NATCO PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs8771,768 49.6%   
Low Rs4241,186 35.7%   
Sales per share (Unadj.) Rs223.4346.1 64.6%  
Earnings per share (Unadj.) Rs31.155.2 56.3%  
Cash flow per share (Unadj.) Rs40.373.3 54.9%  
Dividends per share (Unadj.) Rs5.0014.00 35.7%  
Dividend yield (eoy) %0.80.9 81.1%  
Book value per share (Unadj.) Rs219.5257.1 85.4%  
Shares outstanding (eoy) m33.07169.22 19.5%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.94.3 68.2%   
Avg P/E ratio x20.926.8 78.2%  
P/CF ratio (eoy) x16.120.1 80.2%  
Price / Book Value ratio x3.05.7 51.6%  
Dividend payout %16.125.4 63.4%   
Avg Mkt Cap Rs m21,504249,887 8.6%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m1,1289,934 11.4%   
Avg. sales/employee Rs ThNM4,971.5-  
Avg. wages/employee Rs ThNM843.2-  
Avg. net profit/employee Rs ThNM792.4-  
INCOME DATA
Net Sales Rs m7,38958,569 12.6%  
Other income Rs m1672,233 7.5%   
Total revenues Rs m7,55660,802 12.4%   
Gross profit Rs m1,79313,773 13.0%  
Depreciation Rs m3043,069 9.9%   
Interest Rs m3662,056 17.8%   
Profit before tax Rs m1,29010,881 11.9%   
Minority Interest Rs m460-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3091,545 20.0%   
Profit after tax Rs m1,0279,336 11.0%  
Gross profit margin %24.323.5 103.2%  
Effective tax rate %23.914.2 168.5%   
Net profit margin %13.915.9 87.2%  
BALANCE SHEET DATA
Current assets Rs m3,68153,841 6.8%   
Current liabilities Rs m3,12331,612 9.9%   
Net working cap to sales %7.638.0 19.9%  
Current ratio x1.21.7 69.2%  
Inventory Days Days8997 92.1%  
Debtors Days Days5984 70.1%  
Net fixed assets Rs m7,68542,079 18.3%   
Share capital Rs m331846 39.1%   
"Free" reserves Rs m6,67042,655 15.6%   
Net worth Rs m7,25943,501 16.7%   
Long term debt Rs m95522,408 4.3%   
Total assets Rs m11,957101,250 11.8%  
Interest coverage x4.56.3 71.9%   
Debt to equity ratio x0.10.5 25.5%  
Sales to assets ratio x0.60.6 106.8%   
Return on assets %11.711.3 103.6%  
Return on equity %14.221.5 66.0%  
Return on capital %20.719.6 105.6%  
Exports to sales %39.40-   
Imports to sales %5.70-   
Exports (fob) Rs m2,908NA-   
Imports (cif) Rs m421NA-   
Fx inflow Rs m3,44520,066 17.2%   
Fx outflow Rs m7035,304 13.3%   
Net fx Rs m2,74314,762 18.6%   
CASH FLOW
From Operations Rs m1,44010,127 14.2%  
From Investments Rs m-1,089-7,869 13.8%  
From Financial Activity Rs m-353-1,918 18.4%  
Net Cashflow Rs m-1212 -0.7%  

Share Holding

Indian Promoters % 52.0 71.5 72.8%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 7.0 111.7%  
FIIs % 16.6 12.6 132.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 8.8 295.5%  
Shareholders   25,395 26,511 95.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT LTD.  SUVEN LIFE  

Compare NATCO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 19, 2018 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 5-YR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS